Retrovir (Azt) 50 mg (Zidovudine SYRUP) 50 MG

RETROVIR (AZT) 50 MG Syrup is an antiretroviral medication used to manage HIV infection. This oral syrup, manufactured by ViiV Healthcare ULC in Canada, contains zidovudine as the active ingredient.

Strength

50 MG

Pack Size

240 ML

Manufacturer / TM Owner

VIIV HEALTHCARE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RETROVIR (AZT) 50 MG Syrup is primarily used in the treatment of HIV infection. It works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of the HIV virus. This medication is often part of a combination therapy to manage HIV and improve immune function. People may ask, 'What is RETROVIR (AZT) used for?' and the answer is that it is used to control HIV infection and reduce the risk of disease progression.

Side Effects

Common effects of RETROVIR (AZT) 50 MG Syrup may include nausea, headache, and fatigue. Some individuals might experience changes in appetite or mild gastrointestinal discomfort. These effects vary among users and are not experienced by everyone who takes the medication.

Precautions & Warnings

RETROVIR (AZT) 50 MG Syrup should be handled with care, especially by those with known allergies to zidovudine. It is important to follow the advice of a healthcare provider regarding its use. This medication should be stored at room temperature, away from direct sunlight and moisture.

Avoid Interactions

RETROVUDINE may interact with other medications, including certain antiretrovirals and drugs that affect liver enzymes. It is advisable to consult a healthcare provider before combining RETROVIR (AZT) 50 MG Syrup with other treatments. Alcohol and certain over-the-counter medications may also interact with this syrup.

Frequently Asked Questions

RETROVIR (AZT) 50 MG Syrup is used to manage HIV infection by inhibiting the replication of the virus.

RETROVIR (AZT) 50 MG Syrup should be stored at room temperature, away from direct sunlight and moisture.

Common effects may include nausea, headache, and fatigue, though not everyone experiences these.

RETROVIR (AZT) 50 MG Syrup may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

RETROVIR (AZT) 50 MG Syrup is manufactured by ViiV Healthcare ULC in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.